PACE Forward-Making Pharmacogenomics Testing Available for Real-Life Clinical Utility

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Although pharmacogenomics (PGx) offers the promise of ensuring the right patient receives the right medication at the right dose the first time, gene–drug interaction data have yet to be seamlessly integrated into patients’ health records. PGx testing that is preemptive, adaptable, current, and executable (PACE) overcomes the human and technological barriers to successful implementation, thus capitalizing on the affordable cost of such testing and clinical practice guidelines at the point of prescription ordering.

Original languageEnglish (US)
Pages (from-to)42-44
Number of pages3
JournalClinical pharmacology and therapeutics
Volume105
Issue number1
DOIs
StatePublished - Jan 2019

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'PACE Forward-Making Pharmacogenomics Testing Available for Real-Life Clinical Utility'. Together they form a unique fingerprint.

Cite this